Innovative Rheumatology

Methotrexate and biologics have significantly changed the way rheumatoid arthritis is treated in recent years. Rheumatologists could not realistically avoid joint destruction in rheumatoid arthritis until ten years ago. However, thanks to advancements in treatment, joint deterioration can now be prevented, and the long-term quality of life for rheumatoid arthritis patients has improved. Still, a lot of obstacles need to be removed before rheumatoid arthritis can be effectively treated. Every review article included in this book offers a fresh viewpoint and set of ideas on the diagnosis, treatment, and patient care of rheumatoid arthritis.

  • Methotrexate (Rheumatrex, Trexall)
  • Hydroxychloroquine (Plaquenil)
  • Sulfasalazine (Azulfidine)
  • Leflunomide (Arava)

Related Conference of Rheumatology